InvestorsObserver
×
News Home

Should You Hold Entasis Therapeutics Holdings Inc (ETTX) in Biotechnology Industry?

Friday, June 17, 2022 11:34 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Entasis Therapeutics Holdings Inc (ETTX) in Biotechnology Industry?

A rating of 84 puts Entasis Therapeutics Holdings Inc (ETTX) near the top of the Biotechnology industry according to InvestorsObserver. Entasis Therapeutics Holdings Inc's score of 84 means it scores higher than 84% of stocks in the industry. Entasis Therapeutics Holdings Inc also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 66 out of the 148 industries.

Overall Score - 63
ETTX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ETTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Entasis Therapeutics Holdings Inc Stock Today?

Entasis Therapeutics Holdings Inc (ETTX) stock has fallen -0.44% while the S&P 500 is up 0.11% as of 11:29 AM on Friday, Jun 17. ETTX is down -$0.01 from the previous closing price of $2.19 on volume of 10,124 shares. Over the past year the S&P 500 has fallen -13.06% while ETTX is down -18.96%. ETTX lost -$1.13 per share the over the last 12 months. Click Here to get the full Stock Report for Entasis Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App